Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials

Published:2012-02 Issue: Volume: Page:73
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Kauffman Ken,Doherty Dennis,Kerwin ,Matiz-Bueno ,Knorr ,Shekar ,Gates ,Staudinger

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: A meta-analysis;Medicine;2024-01-19

2. Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-03-27

3. Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2021-06-29

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

;International Journal of Chronic Obstructive Pulmonary Disease;2020-11

5. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials;BMC Pulmonary Medicine;2020-10-28